The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2015
Filed:
May. 29, 2009
Applicants:
Tatsuya Matsukawa, Tokyo, JP;
Kazuhiro Masuzaki, Toyko, JP;
Akiko Kawasaki, Tokyo, JP;
Akiko Akasaka, Tokyo, JP;
Yosuke Kawai, Tokyo, JP;
Inventors:
Tatsuya Matsukawa, Tokyo, JP;
Kazuhiro Masuzaki, Toyko, JP;
Akiko Kawasaki, Tokyo, JP;
Akiko Akasaka, Tokyo, JP;
Yosuke Kawai, Tokyo, JP;
Assignee:
R-Tech Ueno, Ltd., Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); C07D 241/04 (2006.01); C07D 213/74 (2006.01); C07C 243/32 (2006.01); C07C 243/34 (2006.01); C07C 281/02 (2006.01); C07C 281/06 (2006.01); C07D 233/88 (2006.01); C07D 237/20 (2006.01); C07D 239/42 (2006.01); C07D 241/20 (2006.01); C07D 241/24 (2006.01); C07D 265/36 (2006.01); C07D 333/36 (2006.01); C07D 401/04 (2006.01); C07D 409/06 (2006.01); C07D 417/04 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
C07D 213/74 (2013.01); C07C 243/32 (2013.01); C07C 243/34 (2013.01); C07C 281/02 (2013.01); C07C 281/06 (2013.01); C07D 233/88 (2013.01); C07D 237/20 (2013.01); C07D 239/42 (2013.01); C07D 241/20 (2013.01); C07D 241/24 (2013.01); C07D 265/36 (2013.01); C07D 333/36 (2013.01); C07D 401/04 (2013.01); C07D 409/06 (2013.01); C07D 417/04 (2013.01); C07D 487/08 (2013.01);
Abstract
The present invention provides a novel benzene derivative or thiophene derivative useful as a VAP-1 inhibitor, or a medicament for the prophylaxis or treatment of a VAP-1 associated disease and the like, namely, a compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a pharmaceutically acceptable salt thereof.